Latest news

Thumbnail image for CDF to save NHS £140m over five years

CDF to save NHS £140m over five years

At least £140 million is expected to be released into the NHS over the next five years because of price discounts negotiated via the Cancer Drugs Fund.

31st January 2018

Thumbnail image for NHS plans to be first to eliminate hepatitis C

NHS plans to be first to eliminate hepatitis C

NHS England has laid out plans for England to become the first country to eliminate hepatitis C, at least five years earlier than the World Health Organisation’s target date of 2030.

31st January 2018

Thumbnail image for My mHealth, LumiraDx form digital health partnership

My mHealth, LumiraDx form digital health partnership

My mHealth and LumiraDx Care Solutions have partnered to offer digital self-care to millions of patients in the UK, combining the groups’ expertise in clinical management software and digital technology.

30th January 2018

Thumbnail image for Breakthrough status for Roche’s autism drug

Breakthrough status for Roche’s autism drug

Roche’s balovaptan has picked up a Breakthrough Therapy Designation in the US for its potential as a treatment for people with autism spectrum disorder (ASD), potentially placing the drug on a faster path to market.

30th January 2018

Thumbnail image for AZ’ triple combo COPD inhaler hits PhIII targets

AZ’ triple combo COPD inhaler hits PhIII targets

AstraZeneca recently unveiled top-line trial data backing use of an experimental triple combination therapy being developed for use with its Aerosphere technology in patients with chronic obstructive pulmonary disease (COPD).

30th January 2018

Thumbnail image for EU clears MSD’s Prevymis for CMV prevention

EU clears MSD’s Prevymis for CMV prevention

European regulators have approved MSD’s Prevymis for the prevention of cytomegalovirus (CMV) reactivation and disease in prone adults who have received an allogeneic haematopoietic stem cell transplant (HSCT).

30th January 2018

Thumbnail image for Survey reveals low awareness of kidney cancer

Survey reveals low awareness of kidney cancer

A charity survey has highlighted an “urgent need” for earlier diagnosis of kidney cancer, revealing that, in 51 percent of cases, the disease is detected from scans relating to other health conditions.

30th January 2018

Thumbnail image for Sanofi snaps up Ablynx for 3.9bn euros

Sanofi snaps up Ablynx for 3.9bn euros

Sanofi has announced its intention to buy Belgian drugmaker Ablynx via a deal valued at around 3.9 billion Euros, beating Novo Nordisk to the finish line.

29th January 2018

Previous  --   14 15 16 17 18 19 20 21 22 23   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download